United States· US:70518-2491_51dff223-f709-c42d-e063-6294a90abcc3

Benzonatate

A benzonatate product containing benzonatate, registered in United States by REMEDYREPACK INC..

ATC R05DB01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBenzonatateATCR05DB01REGISTER NO.US:70518-2491_51dff22…PACKS LISTED6CHECKEDJuly 26, 2026

Price per daily dose

What a daily dose of benzonatate costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • United States: $0.35 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Benzonatate · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • US United States$0.35 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BENZONATATE
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
R05DB01
ATC class
Benzonatate
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
July 26, 2026

Packs & prices · 6

  • ndc11
    7051824913
    30 CAPSULE in 1 BOTTLE, PLASTIC (70518-2491-3)
  • ndc11
    7051824914
    21 CAPSULE in 1 BOTTLE, PLASTIC (70518-2491-4)
  • ndc11
    7051824915
    20 CAPSULE in 1 BOTTLE, PLASTIC (70518-2491-5)
  • ndc11
    70518-2491-3
  • ndc11
    70518-2491-4
  • ndc11
    70518-2491-5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for benzonatate.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Benzonatate · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • TizanidineM03BX02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d4087b2a-216c-4159-bfb6-ecedae07fe7d
GET /v1/drugs/d4087b2a-216c-4159-bfb6-ecedae07fe7d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "200",
  "substance": "BENZONATATE",
  "productndc": "70518-2491",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA206948",
  "marketing_category": "ANDA"
}

See everything about benzonatate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.